NDASUBLINGUALTABLET
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Clinical Trials (1)
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
Started Nov 2013
33 enrolled
Opioid Dependence
Loss of Exclusivity
LOE Date
Sep 18, 2032
79 months away
Patent Expiry
Sep 18, 2032